Cargando…

What is the impact of post-COVID-19 syndrome on health-related quality of life and associated factors: a cross-sectional analysis

BACKGROUND: After the acute phase, symptoms or sequelae related to post-COVID-19 syndrome may persist for months. In a population of patients, previously hospitalized and not, followed up to 12 months after the acute infection, we aim to assess whether and to what extent post-COVID-19 syndrome may h...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mastrorosa, Ilaria, Del Duca, Giulia, Pinnetti, Carmela, Lorenzini, Patrizia, Vergori, Alessandra, Brita, Anna Clelia, Camici, Marta, Mazzotta, Valentina, Baldini, Francesco, Chinello, Pierangelo, Mencarini, Paola, Giancola, Maria Letizia, Abdeddaim, Amina, Girardi, Enrico, Vaia, Francesco, Antinori, Andrea
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10031164/ https://www.ncbi.nlm.nih.gov/pubmed/36949439 http://dx.doi.org/10.1186/s12955-023-02107-z

Ejemplares similares

Declining Prevalence of Human Immunodeficiency Virus (HIV)–Associated Neurocognitive Disorders in Recent Years and Associated Factors in a Large Cohort of Antiretroviral Therapy–Treated Individuals With HIV
por: Mastrorosa, Ilaria, et al.
Publicado: (2022)

Characteristics and Outcomes of COVID-19-Related Hospitalization among PLWH
por: Gagliardini, Roberta, et al.
Publicado: (2022)

Reactivation of occult HBV infection in an HIV/HCV Co-infected patient successfully treated with sofosbuvir/ledipasvir: a case report and review of the literature
por: Fabbri, Gabriele, et al.
Publicado: (2017)

Sarilumab plus standard of care vs standard of care for the treatment of severe COVID-19: a phase 3, randomized, open-labeled, multi-center study (ESCAPE study)
por: Mastrorosa, Ilaria, et al.
Publicado: (2023)

Humoral and Cellular Immune Response Elicited by mRNA Vaccination Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in People Living With Human Immunodeficiency Virus Receiving Antiretroviral Therapy Based on Current CD4 T-Lymphocyte Count
por: Antinori, Andrea, et al.
Publicado: (2022)

Clinical experience with use of oral Tecovirimat or Intravenous Cidofovir for the treatment of Monkeypox in an Italian reference hospital
por: Mondi, Annalisa, et al.
Publicado: (2023)

A Case of Severe Mpox Complicated with Streptococcus pyogenes Sepsis in a Patient with HIV Infection
por: Di Bari, Silvia, et al.
Publicado: (2023)

No Efficacy of the Combination of Lopinavir/Ritonavir Plus Hydroxychloroquine Versus Standard of Care in Patients Hospitalized With COVID-19: A Non-Randomized Comparison
por: Gagliardini, Roberta, et al.
Publicado: (2021)

Benefits of Steroid Therapy in COVID-19 Patients with Different PaO(2)/FiO(2) Ratio at Admission
por: Vita, Serena, et al.
Publicado: (2021)

Monkeypox virus isolation from a semen sample collected in the early phase of infection in a patient with prolonged seminal viral shedding
por: Lapa, Daniele, et al.
Publicado: (2022)

Role of testosterone in SARS-CoV-2 infection: A key pathogenic factor and a biomarker for severe pneumonia
por: Camici, Marta, et al.
Publicado: (2021)

Ocular involvement in monkeypox: Description of an unusual presentation during the current outbreak
por: Mazzotta, V, et al.
Publicado: (2022)

Emulation of a Target Trial From Observational Data to Compare Effectiveness of Casirivimab/Imdevimab and Bamlanivimab/Etesevimab for Early Treatment of Non-Hospitalized Patients With COVID-19
por: Mazzotta, Valentina, et al.
Publicado: (2022)

Randomized trial of DRV/r or LPV/r QD monotherapy vs maintaining a PI/r-based antiretroviral regimen in persons with suppressed HIV replication
por: Pinnetti, Carmela, et al.
Publicado: (2014)

Use of Pembrolizumab for Treatment of Progressive Multifocal Leukoencephalopathy in People Living with HIV
por: Pinnetti, Carmela, et al.
Publicado: (2022)

Immunogenicity to COVID-19 mRNA vaccine third dose in people living with HIV
por: Vergori, Alessandra, et al.
Publicado: (2022)

Viral load decrease in SARS‐CoV‐2 BA.1 and BA.2 Omicron sublineages infection after treatment with monoclonal antibodies and direct antiviral agents
por: Valentina, Mazzotta, et al.
Publicado: (2022)

Neutralizing activity and T Cell response after bivalent fifth dose of mRNA vaccine in person living with HIV
por: Vergori, Alessandra, et al.
Publicado: (2023)

Spontaneous ilio-psoas haematomas (IPHs): a warning for COVID-19 inpatients
por: Vergori, Alessandra, et al.
Publicado: (2021)

Peripheral blood HIV-1 DNA dynamics in antiretroviral-treated HIV/HCV co-infected patients receiving directly-acting antivirals
por: Rozera, Gabriella, et al.
Publicado: (2017)

Virological Response in Cerebrospinal Fluid to Antiretroviral Therapy in a Large Italian Cohort of HIV-Infected Patients with Neurological Disorders
por: Giancola, Maria Letizia, et al.
Publicado: (2012)

The dual-target approach in viral HIV-1 viremia testing: An added value to virological monitoring?
por: Amendola, Alessandra, et al.
Publicado: (2020)

Correction: The dual-target approach in viral HIV-1 viremia testing: An added value to virological monitoring?
por: Amendola, Alessandra, et al.
Publicado: (2020)

Lymphofollicular lesions associated with monkeypox (Mpox) virus proctitis
por: Mazzotta, Valentina, et al.
Publicado: (2023)

Asymptomatic Mpox Virus Infection in Subjects Presenting for MVA-BN Vaccine
por: Matusali, Giulia, et al.
Publicado: (2023)

Prophylactic heparin and risk of orotracheal intubation or death in patients with mild or moderate COVID-19 pneumonia
por: Vergori, Alessandra, et al.
Publicado: (2021)

Kinetics of viral DNA in body fluids and antibody response in patients with acute Monkeypox virus infection
por: Colavita, Francesca, et al.
Publicado: (2023)

Kinetics of TTV Loads in Peripheral Blood Mononuclear Cells of Early Treated Acute HIV Infections
por: Abbate, Isabella, et al.
Publicado: (2023)

Epidemiological, clinical and virological characteristics of four cases of monkeypox support transmission through sexual contact, Italy, May 2022
por: Antinori, Andrea, et al.
Publicado: (2022)

SARS-CoV-2 Omicron Variant Neutralization after Third Dose Vaccination in PLWH
por: Vergori, Alessandra, et al.
Publicado: (2022)

Treatment-Emergent Cilgavimab Resistance Was Uncommon in Vaccinated Omicron BA.4/5 Outpatients
por: Gruber, Cesare Ernesto Maria, et al.
Publicado: (2023)

APRI and FIB-4 scores are not associated with neurocognitive impairment in HIV-infected persons
por: Libertone, Raffaella, et al.
Publicado: (2014)

Monkeypox virus in human body sites and fluids: evidence for transmission
por: Colavita, Francesca, et al.
Publicado: (2023)

SARS-CoV-2 nasopharyngeal viral load in individuals infected with BA.2, compared to Alpha, Gamma, Delta and BA.1 variants: A single-center comparative analysis
por: Mastrorosa, Ilaria, et al.
Publicado: (2022)

Central nervous system penetration-effectiveness rank does not reliably predict neurocognitive impairment in HIV-infected individuals
por: Libertone, Raffaella, et al.
Publicado: (2014)

SARS-CoV-2 infection does not induce HIV viral escape in the central nervous system: A case series
por: Pinnetti, C., et al.
Publicado: (2020)

Comparison of SARS-CoV-2 Detection in Nasopharyngeal Swab and Saliva Samples from Patients Infected with Omicron Variant
por: Bordi, Licia, et al.
Publicado: (2023)

Viral replication and infectivity of monkeypox through semen – Authors' reply
por: Lapa, Daniele, et al.
Publicado: (2022)

Evidence of Maternal Antibodies Elicited by COVID-19 Vaccination in Amniotic Fluid: Report of Two Cases in Italy
por: Colavita, Francesca, et al.
Publicado: (2022)

Immunological signature in human cases of monkeypox infection in 2022 outbreak: an observational study
por: Agrati, Chiara, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_pna12hv8170q3gnd3nbvht8902